Michallet, Anne-Sophie <br/><br/>
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.  [electronic resource] 

 -  American journal of hematology  06 2017 
 - E105-E107 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1096-8652 
<br/><br/><label>Standard No.: </label>10.1002/ajh.24715  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Cardiovascular Diseases--chemically induced<br/>Dose-Response Relationship, Drug<br/>Female<br/>France--epidemiology<br/>Gastrointestinal Diseases--chemically induced<br/>Hematologic Diseases--chemically induced<br/>Humans<br/>Infections--etiology<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Male<br/>Molecular Targeted Therapy<br/>Piperidines<br/>Protein Kinase Inhibitors--administration & dosage<br/>Pyrazoles--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Salvage Therapy<br/>Treatment Outcome